Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Date of authorisation: 13/01/2016, Revision: 28, Status: Authorised

Submitted by Anonymous (not verified) on 27 January 2026 - 9:08

Human medicines European public assessment report (EPAR): Briviact (in Italy: Nubriveo), brivaracetam, Date of authorisation: 13/01/2016, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Date of authorisation: 06/03/2025, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 27 January 2026 - 9:00

Human medicines European public assessment report (EPAR): Wainzua, eplontersen, Date of authorisation: 06/03/2025, Revision: 1, Status: Authorised

Q&A clinic on Substance, Organisation, Referentials Management Services - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 January 2026, 11:00 (CET) to 13 January 2026, 12:00 (CET)

Submitted by Anonymous (not verified) on 27 January 2026 - 8:54

Q&A clinic on Substance, Organisation, Referentials Management Services - January 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 January 2026, 11:00 (CET) to 13 January 2026, 12:00 (CET)

Human medicines European public assessment report (EPAR): Levetiracetam Actavis, levetiracetam, Date of authorisation: 03/10/2011, Revision: 21, Status: Authorised

Submitted by Anonymous (not verified) on 26 January 2026 - 16:47

Human medicines European public assessment report (EPAR): Levetiracetam Actavis, levetiracetam, Date of authorisation: 03/10/2011, Revision: 21, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness